Phase 1 Placebo-controlled,Dose-escalation Study to Evaluate the Safety and Pharmacokinetics of MEDI8852 in Adults
Clinical trial NCT02350751 · COMPLETED
Trial details
- NCT number
- NCT02350751
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2015-06-01
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.